CAXTON CORP
CIK 1388551 · View on SEC EDGAR ↗
- Portfolio value
- $4.0M
- Positions
- 7
- As of
- March 31, 2026 Data as of Q1 2026
#8,319 of 8,643 by 13F value · top 96.3%
Portfolio value QoQ: -6.0% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 10
- Effective number of positions
- 6.6
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 38.83% Est. buys $1,141,122 · sells $3,337,177
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 41.7% still held
- New positions
- 4
- Increased
- 2
- Decreased
- 1
- Closed
- 1
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
19.6%
Communication Services
13.3%
Financial Services
10.2%
Other/Unmapped
57.0%
Full portfolio 10 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: 84615Q103) | $445,346 | 24.03% | 2,606 | Up ×1 | |||
| BRKB | $377,128 | 20.35% | 754 | $28,787 | Up ×5 | ||
| GOOGL Alphabet Inc. - Class A Common Stock | $246,906 | 13.32% | 691 | Up ×1 | |||
| VOO | $233,094 | 12.58% | 339 | Up ×1 | |||
| BX Blackstone Inc. Common Stock | $188,218 | 10.16% | 1,597 | Up ×1 | |||
| KYTX Kyverna Therapeutics, Inc. - Common Stock | $110,009 | 5.94% | 12,347 | $-52,003 | Down ×1 | ||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $78,959 | 4.26% | 16,962 | $-1,073 | Up ×1 | ||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $72,650 | 3.92% | 15,557 | $8,401 | |||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $57,759 | 3.12% | 28,453 | $9,958 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $43,358 | 2.34% | 20,946 | $1,362 | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
| Security | Value | % of portfolio | Streak |
|---|---|---|---|
| BRKB | $377,128 | 20.35% | up ×5 |
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| RZLT | Dec. 31, 2025 | 1,986,818 | $18,676,089 | 104.0% |
| XERS | March 31, 2025 | 2,015,157 | $6,831,382 | 63.2% |
| GLD | June 30, 2026 | 7,623 | $3,279,923 | No longer tracked |
| SPY | March 31, 2025 | 2,823 | $1,654,494 | No longer tracked |
| SYRE | March 31, 2026 | 8,919 | $292,194 | 109.4% |
| ELVN | Dec. 31, 2025 | 13,097 | $268,106 | 282.9% |
| MNMD | March 31, 2026 | 15,688 | $210,058 | No longer tracked |
| BCAX | Dec. 31, 2025 | 10,941 | $172,760 | 55.5% |
| CMPX | March 31, 2026 | 29,495 | $158,386 | -53.0% |
| GLYC | March 31, 2025 | 203,578 | $50,895 | No longer tracked |
| CRDF | June 30, 2025 | 13,287 | $41,721 | -71.3% |
| SABS | March 31, 2026 | 10,527 | $39,371 | 0.5% |
| CNTX | March 31, 2026 | 18,403 | $27,053 | -82.0% |
| ACET | June 30, 2025 | 17,488 | $13,203 | 1430.3% |